147 related articles for article (PubMed ID: 2576594)
21. Antibodies to the HIV-1 V3 loop in serum from infected persons contribute a major proportion of immune effector functions including complement activation, antibody binding, and neutralization.
Spear GT; Takefman DM; Sharpe S; Ghassemi M; Zolla-Pazner S
Virology; 1994 Nov; 204(2):609-15. PubMed ID: 7941328
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
Schulte C; Meurer M; Fröschl M
Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
[TBL] [Abstract][Full Text] [Related]
23. Biological significance of the antibody response to HIV antigens expressed on the cell surface.
Goudsmit J; Ljunggren K; Smit L; Jondal M; Fenyö EM
Arch Virol; 1988; 103(3-4):189-206. PubMed ID: 3265052
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
[TBL] [Abstract][Full Text] [Related]
25. MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac.
Charaf B; Sanhadji K; Sekkat S; Farouqui B; Touraine JL; Benslimane A
Thymus; 1993 Aug; 22(1):1-12. PubMed ID: 7905683
[TBL] [Abstract][Full Text] [Related]
26. Effect of HIV-1 infection on CD4 cells in a hemophilia cohort.
Green D; Deutsche J; Tang M; Goldsmith J
Haematologica; 1990; 75 Suppl 5():132-41. PubMed ID: 1982277
[No Abstract] [Full Text] [Related]
27. Immunological status and HIV antibodies in patients with haemophilia--a longitudinal study.
Fuchs D; Hausen A; Reibnegger G; Werner ER; Vinazzer H; Dierich MP; Wachter H
Wien Klin Wochenschr; 1988 Aug; 100(15):505-9. PubMed ID: 3140497
[TBL] [Abstract][Full Text] [Related]
28. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
Ljunggren K; Karlson A; Fenyö EM; Jondal M
Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
[TBL] [Abstract][Full Text] [Related]
29. [Antigens of the human immunodeficiency virus in serum of high risk people in the city of Monterrey].
Salinas Carmona MC; Flores de Castañeda MS; Garza Elizondo MA; Pérez Rivera LI
Rev Invest Clin; 1989; 41(2):129-32. PubMed ID: 2781175
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
Lusso P; Markham PD; Ranki A; Earl P; Moss B; Dorner F; Gallo RC; Krohn KJ
J Immunol; 1988 Oct; 141(7):2467-73. PubMed ID: 3262661
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
[TBL] [Abstract][Full Text] [Related]
32. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.
Stricker RB; McHugh TM; Moody DJ; Morrow WJ; Stites DP; Shuman MA; Levy JA
Nature; 1987 Jun 25-Jul 1; 327(6124):710-3. PubMed ID: 2955226
[TBL] [Abstract][Full Text] [Related]
33. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.
Füst G; Tóth FD; Kiss J; Ujhelyi E; Nagy I; Bánhegyi D
AIDS; 1994 May; 8(5):603-9. PubMed ID: 7914732
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in HIV-infected hemophilia patients against different epitopes on CD4+ lymphocytes and recombinant CD4.
Daniel V; Weimer R; Zettlmeissl G; Langner K; Zimmermann R; Opelz G
Vox Sang; 1992; 62(1):39-44. PubMed ID: 1374580
[TBL] [Abstract][Full Text] [Related]
35. Decline of anti-DP107 antibody associated with clinical progression.
Hattori T; Komoda H; Pahwa S; Tateyama M; Zhang X; Xu Y; Oguma S; Tamamura H; Fujii N; Fukutake K; Uchiyama T
AIDS; 1998 Aug; 12(12):1557-9. PubMed ID: 9727582
[No Abstract] [Full Text] [Related]
36. Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients.
McHugh TM; Stites DP; Busch MP; Krowka JF; Stricker RB; Hollander H
J Infect Dis; 1988 Nov; 158(5):1088-91. PubMed ID: 3141521
[No Abstract] [Full Text] [Related]
37. AIDS and hemophilia.
Koerper MA
Immunol Ser; 1989; 44():79-95. PubMed ID: 2489127
[No Abstract] [Full Text] [Related]
38. Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients.
Chia WK; Blanchette V; Mody M; Wright JF; Freedman J
Br J Haematol; 1998 Dec; 103(4):1014-22. PubMed ID: 9886313
[TBL] [Abstract][Full Text] [Related]
39. Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.
Blumberg RS; Paradis T; Hartshorn KL; Vogt M; Ho DD; Hirsch MS; Leban J; Sato VL; Schooley RT
J Infect Dis; 1987 Dec; 156(6):878-84. PubMed ID: 3479500
[TBL] [Abstract][Full Text] [Related]
40. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.
Montefiori DC; Pantaleo G; Fink LM; Zhou JT; Zhou JY; Bilska M; Miralles GD; Fauci AS
J Infect Dis; 1996 Jan; 173(1):60-7. PubMed ID: 8537683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
